Private Equity: Meridian’s private equity and venture investments seek to apply growth equity capital at precise investment windows. Our investments span industries and stages, however are linked by Meridian’s active role, existing strength of management, and an entrepreneurial commitment to social impact.

• Spring 2011: Meridian closed a growth equity investment in a US-based biofuel producer. The investment will provide growth capital to restart operations at the waste oil-to-fuel plant, as well as for physical expansion and new facilities. The company is poised to be a significant contributor to the US biofuel industry.
  
  
• Winter 2010: Meridian closed on an investment in a major US affordable housing owner and manager. The investment PROVIDED INVESTORS WITH strong cash flows, solid downside protection via federally guaranteed rents, and significant expansion potential. The recapitalization will position the company to continue its acquisition strategy in affordable housing across the US.
  
  
• 2006: Meridian placed an angel investment in Oncovax, the maker of Vaccinogen, a cancer vaccine. The investment will assist Oncovax to bring its product through the final research and development stages and subsequently to market.